SESN
Income statement / Annual
Last year (2022), Sesen Bio, Inc.'s total revenue was $40.00 M,
an increase of 50.69% from the previous year.
In 2022, Sesen Bio, Inc.'s net income was -$19.88 M.
See Sesen Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$40.00 M
|
$26.54 M
|
$11.24 M
|
$0.00
|
$0.00
|
$425,000.00
|
$29.98 M
|
$990,000.00
|
$2.24 M
|
$1.33 M
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$40.00 M |
$26.54 M |
$11.24 M |
$0.00 |
$0.00 |
$425,000.00 |
$29.98 M |
$990,000.00 |
$2.24 M |
$1.33 M |
| Gross Profit Ratio |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$38.59 M
|
$25.31 M
|
$29.19 M
|
$24.66 M
|
$14.08 M
|
$12.51 M
|
$13.48 M
|
$26.34 M
|
$26.70 M
|
$13.79 M
|
| General & Administrative
Expenses |
$39.79 M
|
$29.39 M
|
$14.30 M
|
$12.21 M
|
$11.62 M
|
$8.07 M
|
$14.74 M
|
$9.85 M
|
$8.47 M
|
$4.02 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$39.79 M
|
$29.39 M
|
$14.30 M
|
$12.21 M
|
$11.62 M
|
$8.07 M
|
$14.74 M
|
$9.85 M
|
$8.47 M
|
$4.02 M
|
| Other Expenses |
$296,000.00 |
-$60,000.00 |
$125,000.00 |
$991,000.00 |
$807,000.00 |
$226,000.00 |
-$723,000.00 |
$3.14 M |
-$849,000.00 |
-$147,000.00 |
| Operating Expenses |
$78.38 M |
$54.71 M |
$43.49 M |
$36.87 M |
$25.70 M |
$20.58 M |
$28.22 M |
$36.19 M |
$35.17 M |
$17.81 M |
| Cost And Expenses |
$78.38 M |
$54.71 M |
$43.49 M |
$36.87 M |
$25.70 M |
$20.58 M |
$28.22 M |
$36.19 M |
$35.17 M |
$17.81 M |
| Interest Income |
$1.85 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$247,000.00 |
$1.40 M |
$376,000.00 |
$1.40 M |
| Depreciation &
Amortization |
-$24.93 M
|
-$39.14 M
|
-$22.24 M
|
$219,000.00
|
$9.82 M
|
$285,000.00
|
$178,000.00
|
$366,000.00
|
$410,000.00
|
$438,000.00
|
| EBITDA |
-$50.84 M
|
-$8.55 M
|
-$21.08 M
|
$34.97 M
|
-$24.69 M
|
-$19.64 M
|
$2.87 M
|
-$31.69 M
|
-$32.93 M
|
-$16.19 M
|
| EBITDA Ratio |
-1.27 |
-1.8 |
-3.86 |
0 |
0 |
-46.22 |
0.04 |
-32.01 |
-14.88 |
-12.13 |
| Operating Income Ratio
|
-0.65
|
-0.32
|
-1.88
|
0
|
0
|
-68.84
|
0.1
|
-35.55
|
-14.68
|
-12.35
|
| Total Other
Income/Expenses Net |
$2.15 M
|
-$60,000.00
|
$125,000.00
|
$991,000.00
|
$807,000.00
|
$226,000.00
|
-$970,000.00
|
$3.14 M
|
-$1.23 M
|
-$147,000.00
|
| Income Before Tax |
-$23.76 M |
-$8.61 M |
-$20.95 M |
-$107.50 M |
-$33.69 M |
-$29.03 M |
$1.90 M |
-$33.45 M |
-$34.16 M |
-$18.03 M |
| Income Before Tax Ratio
|
-0.59
|
-0.32
|
-1.86
|
0
|
0
|
-68.3
|
0.06
|
-33.79
|
-15.23
|
-13.51
|
| Income Tax Expense |
-$3.88 M |
-$8.27 M |
$1.45 M |
$71.62 M |
$807,000.00 |
$226,000.00 |
$5,000.00 |
$4.53 M |
-$473,000.00 |
$1.25 M |
| Net Income |
-$19.88 M |
-$336,000.00 |
-$22.40 M |
-$179.12 M |
-$34.50 M |
-$29.03 M |
$1.89 M |
-$33.45 M |
-$34.16 M |
-$18.03 M |
| Net Income Ratio |
-0.5 |
-0.01 |
-1.99 |
0 |
0 |
-68.3 |
0.06 |
-33.79 |
-15.23 |
-13.51 |
| EPS |
-1.99 |
-0.0369 |
-3.79 |
-39.4 |
-11.17 |
-22.24 |
1.8 |
-35.23 |
-46.65 |
-1.17 |
| EPS Diluted |
-1.99 |
-0.0369 |
-3.79 |
-39.4 |
-11.17 |
-22.24 |
1.8 |
-35.23 |
-46.65 |
-1.17 |
| Weighted Average Shares
Out |
$9.97 M
|
$9.12 M
|
$5.91 M
|
$4.55 M
|
$3.09 M
|
$1.31 M
|
$1.05 M
|
$949,650.00
|
$732,200.00
|
$15.39 M
|
| Weighted Average Shares
Out Diluted |
$9.97 M
|
$9.12 M
|
$5.91 M
|
$4.55 M
|
$3.09 M
|
$1.31 M
|
$1.09 M
|
$949,650.00
|
$732,200.00
|
$15.39 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
